Eye Diseases
Diseases affecting the eye.
Subtype terms (26)
More specific conditions that are subtypes of Eye Diseases in the MeSH hierarchy.
- Asthenopia
10 drugs (1 approved, 9 experimental)
- Cogan Syndrome
3 drugs approved
- Conjunctival Diseases
3 drugs (1 approved, 2 experimental)
- Corneal Diseases
109 drugs (60 approved, 49 experimental)
- Eye Abnormalities
1 drug experimental
- Eye Diseases, Hereditary
35 drugs (18 approved, 17 experimental)
- Eye Hemorrhage
- Eye Infections
12 drugs (8 approved, 4 experimental)
- Eye Injuries
2 drugs experimental
- Eyelid Diseases
10 drugs (9 approved, 1 experimental)
- Eye Manifestations
2 drugs approved
- Eye Neoplasms
8 drugs (4 approved, 4 experimental)
- Lacrimal Apparatus Diseases
14 drugs (7 approved, 7 experimental)
- Lens Diseases
6 drugs (5 approved, 1 experimental)
- Ocular Hypertension
94 drugs (38 approved, 56 experimental)
- Ocular Hypotension
- Ocular Motility Disorders
3 drugs approved
- Optic Nerve Diseases
6 drugs (4 approved, 2 experimental)
- Orbital Diseases
5 drugs (3 approved, 2 experimental)
- Pupil Disorders
3 drugs approved
- Refractive Errors
19 drugs (17 approved, 2 experimental)
- Retinal Diseases
113 drugs (64 approved, 49 experimental)
- Scleral Diseases
- Uveal Diseases
3 drugs approved
- Vision Disorders
27 drugs (14 approved, 13 experimental)
- Vitreous Detachment
9 drugs (8 approved, 1 experimental)
Drugs by status
Approved for this indication (12)
Phase 4 trials (14)
Phase 3 trials (15)
Phase 2 trials (21)
Phase 1 trials (15)
Organizations
Organization Involved with Phase 4 Indications (51)
- Shire
- Bausch & Lomb
- Merck
- Novartis
- Allergan
- Santen Inc.
- Glaukos Corporation
- GlaxoSmithKline
- Horizon Therapeutics, LLC
- Mallinckrodt
- Ocular Therapeutix, Inc.
- Sun Pharmaceuticals
- Taejoon Pharm Co., Ltd.
- Lifelong Vision Foundation
- Region Skane
- Edward Holland, MD
- University of Pennsylvania
- Chang Gung University
- University of London
- Harvard University
- Hermann Eye Center
- Medical University of Warsaw
- Ophthalmic Consultants of Long Island
- Stanford University
- Tufts University
- University of Pisa
- University of Toronto
- Yonsei University
- Cardiff University
- Dalian Medical University
- +21 more
Organization Involved with Phase 3 Indications (51)
- Inspire Pharmaceuticals
- Horizon Pharma
- Senju Pharmaceuticals
- Aldeyra Therapeutics, Inc.
- Bayer
- Can-Fite BioPharma
- Hanlim Pharm. Co., Ltd.
- Kala Pharmaceuticals, Inc.
- Lantibio
- Mimetogen Pharmaceuticals USA, Inc.
- Ocular Technologies SARL
- OmegaD LLC
- Physician Recommended Nutriceuticals
- ProQR Therapeutics
- Sponsor GmbH
- Chong Kun Dang Pharmaceutical
- Novaliq GmbH
- PharmaMar
- National Institutes of Health (NIH)
- National Center for Complementary and Integrative Health (NCCIH)
- National Center for Research Resources (NCRR)
- National Eye Institute (NEI)
- National Heart, Lung, and Blood Institute (NHLBI)
- National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
- Shahid Beheshti University of Medical Sciences
- Cedars-Sinai Medical Center
- Centre Hospitalier Intercommunal Creteil
- Lund University
- Mayo Clinic
- Assiut University
- +21 more
Organization Involved with Phase 2 Indications (56)
- Regeneron
- ISTA Pharmaceuticals
- Adverum Biotechnologies, Inc.
- Kowa
- Ipsen
- Palatin Technologies
- Aerie Pharmaceuticals
- Aurinia Pharmaceuticals Inc.
- C.T. Development America, Inc.
- GL Pharm Tech Corporation
- InSite Vision
- Neothetics, Inc
- ORA, Inc.
- Parion Sciences
- River Vision Development Corporation
- Tyrogenex
- Amakem, NV
- Price Vision Group
- Silkiss, Rona Z., M.D., FACS
- Cornell University
- Katholieke Universiteit Leuven
- Johns Hopkins University
- Manhattan Eye, Ear & Throat Hospital
- Seoul National University
- Sheffield Hallam University
- University of Michigan
- University of Southern Denmark
- University of California, San Francisco
- University of Copenhagen
- Andover Eye Associates
- +26 more
Organization Involved with Phase 1 Indications (11)
Organization Involved with Other Experimental Indications (21)
- Tissue Tech Inc.
- National Cancer Institute (NCI)
- Huazhong University of Science and Technology
- Aarhus University
- Aston University
- Barwon Health
- Instituto Nacional de Ciencias Medicas y Nutricion Salvador Zubiran
- Ohio State University
- Panhandle Eye Group, LLP
- Singapore National Eye Centre
- University of Melbourne
- University of Sydney
- Columbia University
- Icahn School of Medicine at Mount Sinai
- International Thyroid Eye Disease Society
- National Health and Medical Research Council, Australia
- TearLab Corporation
- International Stem Cell Forum
- Velux Fonden
- The University of Texas, Dallas
- General Hospital of Athens Elpis